115996-72-0 Usage
Uses
Used in Pharmaceutical Industry:
2H-Pyran-4-carboxylic acid, tetrahydro-4-hydroxy-, methyl ester (9CI) is used as a building block for the synthesis of pharmaceutical compounds due to its unique cyclic structure and functional groups. Its presence in the synthesis process allows for the creation of diverse drug candidates with potential therapeutic effects on various medical conditions and diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2H-Pyran-4-carboxylic acid, tetrahydro-4-hydroxy-, methyl ester (9CI) is employed as an intermediate for the development of novel bioactive compounds. Its structural features and reactivity contribute to the exploration of structure-activity relationships, aiding researchers in understanding the molecular interactions between drug candidates and their biological targets.
Used in Organic Synthesis:
2H-Pyran-4-carboxylic acid, tetrahydro-4-hydroxy-, methyl ester (9CI) is utilized as a key intermediate in organic synthesis, enabling the formation of complex organic molecules with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science. Its versatility and reactivity make it a valuable component in the synthesis of a wide range of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 115996-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,9,9 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 115996-72:
(8*1)+(7*1)+(6*5)+(5*9)+(4*9)+(3*6)+(2*7)+(1*2)=160
160 % 10 = 0
So 115996-72-0 is a valid CAS Registry Number.
115996-72-0Relevant academic research and scientific papers
Anesthetic compounds and related methods of use
-
, (2015/11/09)
Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
